IP Library › Granted Patent US 10,561,763
Granted Patent B2
US 10,561,763 · App. 15/678,281 · Granted Feb 18, 2020

Oxygen generating biomaterial

Inventors: Henry Ralph Rawls (San Antonio, TX); Ahsan Ullah Khan (New York, NY)
Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
A61L27/54A61C8/0006A61F13/0206A61K31/01A61K31/357A61L15/44A61L27/52A61L2300/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,561,763
App. No.
15/678,281
Granted
Feb 18, 2020
Kind
B2
Abstract

Certain embodiments include materials that carry oxygen and emit molecular oxygen upon heating. The approach reported here uses thermal decomposition of organic endoperoxide compounds to produce singlet oxygen. In certain aspects the oxygen carrier comprises an organic compound either alone or contained in a polymeric carrier or other carrier material that is used to form a coating, layer, or bulk substance that can be a solid, a gel or a fluid. The oxygen-carrier is most conveniently prepared by oxidation of a precursor compound, the structure of which determines its thermal stability and thus how rapidly oxygen is released at any given temperature.

Claims (12)

1. An oxygen-generating material in the form of a wound covering comprising:

(a) an absorbent material selected from the group consisting of carboxymethylcellulose, pectin, and gelatin, and

(b) a rubrene endoperoxide; and

(c) a singlet oxygen quencher that forms triplet oxygen, wherein the singlet oxygen quencher is beta-carotene or 1,3-diphenylisobenzofuran.

2. An oxygen-generating material in the form of a tissue implant for facilitating growth of new tissues, comprising:

(a) a polymer selected from the group consisting of polyglycoside, polylactide, polyether esters, poly(lactide-co-glycolide) and polyhydroxyalkonates, and

(b) a rubrene endoperoxide; and

(c) a singlet oxygen quencher that forms triplet oxygen, wherein the singlet oxygen quencher is beta-carotene or 1,3-diphenylisobenzofuran.

3. The tissue scaffold of claim 2 , wherein the tissue implant is a dental implant.

4. The tissue scaffold of claim 3 , wherein the dental implant is a sub-gingival implant.

5. The material of claim 2 , further comprising a carrier.

6. The material of claim 5 , wherein the carrier is a solid, gel, hydrogel, or semisolid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2017
From: RAWLS, HENRY RALPH; KHAN, AHSAN ULLAH
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 043304/0255 →
Continuity (3)
Division 15034668
Provisional Application 61900915 · Nov 6, 2013
Related Publication 20170368228A1 · Dec 28, 2017